Nearly 300 abstracts on prostate cancer research from around the world will be presented at the European Association of Urology Congress (EAU26 ...

The company's platform integrates genomic sequencing, clinical data analytics, and AI-driven insights across oncology, cardiology, and neuropsychiatry. Tempus serves more than 50% of U.S. oncologists ...

The AI medical imaging market is projected to hit nearly $20 billion by 2033, growing at a 34.7% CAGR([1]) . Echocardiography alone is forecast to grow to $2.64 billion by 2030 as hospitals demand ...

RadNet (NASDAQ:RDNT) executives highlighted record fourth-quarter results and outlined plans to accelerate growth in 2026, ...

RadNet (RDNT) reports record Q4 2025 revenue of $547.7M, up 14.8%, with Digital Health surging 48% and strong 2026 guidance driven by AI growth.

Based in Paris, France, Gleamer serves over 700 customer contracts worldwide with a broad portfolio of FDA-cleared and CE-marked solutions for musculoskeletal, breast, lung and neurologic applications ...

Lord Brady discovered he had the disease after taking a PSA blood test that indicates cancer risk. This was followed by two ...

King Faisal Specialist Hospital and Research Centre (KFSH) in Riyadh has successfully introduced a pioneering high-intensity focused ultrasound (HIFU) treatment for prostate cancer for the first time ...

Certain cancers can now be frozen inside your body. Yes, you heard it right. In what could be a significant leap in minimally invasive oncology, Liverpool Hospi ...

Full-body MRIs are all the rage. Celebrities and influencers tout the benefits of such scans that could find asymptomatic aneurysms and cancers lurking in your body. Sometimes, they're life-saving.

The drug makes prostate cancer easier to detect and stage because it attaches to the cancer cells themselves. This marks the third PSMA‑targeted radiopharmaceutical manufactured at Huntsman Cancer ...

ULTRA-HIGH-FIELD 5 Tesla (T) MRI delivers superior image quality and improved diagnostic performance compared with standard 3 T MRI for prostate cancer (PCa), according to a prospective ...